Patient Characteristics
| Characteristic | Donepezil-treated patients (n = 15) | Placebo-treated patients (n = 20) |
|---|---|---|
| Mean age ±SD (y) | 69.3 ± 6.9 | 71.2 ± 5.6 |
| Age range (y) | (57–80) | (57–79) |
| Sex (M/F) | 9/6 | 13/7 |
| Mean global CBF ± SD (mL/100 g/min) | ||
| Baseline | 35.9 ± 3.4 | 36.8 ± 4.3 |
| Follow-up | 35.5 ± 2.7 | 35.4 ± 4.4 |